Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)

Overview of attention for article published in Thrombosis Journal, May 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,330 followers.

RT @Thrombosis_J: #OpenAccess #Thrombosis Clinical trial assessing the safety of edoxaban with concomitant #chemotherapy in patients with…

RT @Thrombosis_J: #OpenAccess #Thrombosis Clinical trial assessing the safety of edoxaban with concomitant #chemotherapy in patients with…

#OpenAccess #Thrombosis Clinical trial assessing the safety of edoxaban with concomitant #chemotherapy in patients with gynecological cancer-associated thrombosis Read the full article here: https://t.co/A2QCADy6Xq https://t.co/u5dYmOl7Wl

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.